Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kate Cuschieri

Showing results (81-90 of 132) with videos related to

Pageof 14
Sort By:
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 21, 2013
Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK)Ned Powell, Kate Cuschieri, Heather Cubie, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2018
Validation of EUROArray HPV test using the VALGENT frameworkJessica Viti, Mario Poljak, Anja Oštrbenk, et al.
Journal of Medical Virology|September 21, 2005
High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, GabonAli Si-Mohamed, Angélique Ndjoyi-Mbiguino, Kate Cuschieri, et al.
Gynecologic Oncology|April 22, 2010
HPV genotype distribution according to severity of cervical neoplasiaKatrine D Sjoeborg, Ameli Tropé, Agnes Kathrine Lie, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 2, 2014
Clinical performance of RNA and DNA based HPV testing in a colposcopy setting: Influence of assay target, cut off and ageKate Cuschieri, Heather Cubie, Catriona Graham, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 30, 2022
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issuesSuzanne M Garland, Thomas Iftner, Kate Cuschieri, et al.
International Journal of Cancer|February 5, 2016
Use of HPV testing for cervical screening in vaccinated women--Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) studyRamya Bhatia, Kimberley Kavanagh, Heather Ann Cubie, et al.
WHO South-East Asia Journal of Public Health|June 16, 2017
Evidence of HPV subtypes linked with cervical cancer in NepalChop L Bhusal, Sulochana Manandhar, Meeta Singh, et al.
Journal of Virological Methods|April 25, 2021
Evaluation of HarmoniaHPV test for detection of clinically significant Human Papillomavirus infection using the VALGENT frameworkRamya Bhatia, Elia Alcañiz Boada, Jesper Bonde, et al.
Journal of Medical Virology|December 21, 2022
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 frameworkSharonjit K Dhillon, Clementina E Cocuzza, Pui Yan Jenny Chung, et al.
Pageof 14

Showing results (81-90 of 132) with videos related to

Sort By:
Pageof 14
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 21, 2013
Cervical cancers associated with human papillomavirus types 16, 18 and 45 are diagnosed in younger women than cancers associated with other types: a cross-sectional observational study in Wales and Scotland (UK)Ned Powell, Kate Cuschieri, Heather Cubie, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|September 18, 2018
Validation of EUROArray HPV test using the VALGENT frameworkJessica Viti, Mario Poljak, Anja Oštrbenk, et al.
Journal of Medical Virology|September 21, 2005
High prevalence of high-risk oncogenic human papillomaviruses harboring atypical distribution in women of childbearing age living in Libreville, GabonAli Si-Mohamed, Angélique Ndjoyi-Mbiguino, Kate Cuschieri, et al.
Gynecologic Oncology|April 22, 2010
HPV genotype distribution according to severity of cervical neoplasiaKatrine D Sjoeborg, Ameli Tropé, Agnes Kathrine Lie, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|January 2, 2014
Clinical performance of RNA and DNA based HPV testing in a colposcopy setting: Influence of assay target, cut off and ageKate Cuschieri, Heather Cubie, Catriona Graham, et al.
Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology|December 30, 2022
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issuesSuzanne M Garland, Thomas Iftner, Kate Cuschieri, et al.
International Journal of Cancer|February 5, 2016
Use of HPV testing for cervical screening in vaccinated women--Insights from the SHEVa (Scottish HPV Prevalence in Vaccinated Women) studyRamya Bhatia, Kimberley Kavanagh, Heather Ann Cubie, et al.
WHO South-East Asia Journal of Public Health|June 16, 2017
Evidence of HPV subtypes linked with cervical cancer in NepalChop L Bhusal, Sulochana Manandhar, Meeta Singh, et al.
Journal of Virological Methods|April 25, 2021
Evaluation of HarmoniaHPV test for detection of clinically significant Human Papillomavirus infection using the VALGENT frameworkRamya Bhatia, Elia Alcañiz Boada, Jesper Bonde, et al.
Journal of Medical Virology|December 21, 2022
Evaluation of the clinical performance of OncoPredict HPV® SCR assay within the VALGENT-2 frameworkSharonjit K Dhillon, Clementina E Cocuzza, Pui Yan Jenny Chung, et al.
Pageof 14